Plasma vaporization of the prostate for treatment of benign prostatic hypertrophy a review of clinical and cost-effectiveness, and safety

This review aims to review the clinical efficacy, safety and cost-effectiveness of bipolar plasma vaporization of the prostate (BPVP) for the treatment of benign prostatic hyperplasia (BPH) as compared to transurethral resection of the prostate (TURP)

Bibliographic Details
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 5 March 2014, 2014
Series:Rapid response report: summary with critical appraisal
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:This review aims to review the clinical efficacy, safety and cost-effectiveness of bipolar plasma vaporization of the prostate (BPVP) for the treatment of benign prostatic hyperplasia (BPH) as compared to transurethral resection of the prostate (TURP)
Item Description:Title from PDF caption title. - "CADTH Rapid Response Service."
Physical Description:1 PDF file (16 pages) illustrations